Pharmagen ApS: Financial statements 2023
CVR: 36687193
Source: annual report 2023, Danish Business Authority
01/10/2022 – 30/09/2023
Pharmagen ApS (CVR 36687193) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -10,057 and a net result of DKK 15,308 compared with DKK -242,071 the year before. Equity in the 2023 report amounted to DKK -291,860.
- Gross Profit
- DKK -10,057
- Profit/Loss
- DKK 15,308
- Equity
- DKK -291,860
- Total Assets
- DKK 951,948
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -10 t. | 15 t. | -292 t. | 0 |
| 2022 | - | 8 t. | -242 t. | -307 t. | - |
| 2021 | - | 337 t. | 383 t. | -65 t. | - |
| 2020 | - | 373 t. | 76 t. | -448 t. | - |
| 2019 | - | 382 t. | -907 t. | -524 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationAbout Pharmagen ApS
Pharmagen ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2015. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Mads Juul Hedegaard. The company is owned by Hans-Ole Hedegaard. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -15,933 and a net result of DKK 36,023 compared with DKK -19,304 the year before. Equity in the 2025 report amounted to DKK -275,141.